drugset / Trial / NCT05930080

Efficacy and Safety of SKCPT in Patients With Knee Osteoarthritis: Phase III Clinical Trial

NCT05930080

Phase 3 Completed 278 enrolled SK Chemicals Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

Multi-center, Randomized, Double Blinded, Active-controlled Phase III Clinical Trial to Assess the Efficacy and Safety of SKCPT in Patients with knee Osteoarthritis

Timeline

Start
2021-01-28
Primary completion
2022-05-19
Completion
2022-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified
Subject SKCPT Unknown

Indications